Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SUMO2 | P61956 | 1/20 | 0.58 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.58 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.58 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.58 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29697057 | 1.00 | SUMO2 (0.58) | SUMO2SUMO1SENP7SENP2SENP1 | |
| SCHEMBL15120163 | 1.00 | SUMO2 (0.58) | SUMO2SUMO1SENP7SENP2SENP1 | |
| SCHEMBL14988339 | 0.99 | SUMO2 (0.57) | SUMO2SUMO1SENP7SENP2SENP1 | |
| SCHEMBL14988342 | 0.99 | SUMO2 (0.57) | SUMO2SUMO1SENP7SENP2SENP1 | |
| SCHEMBL18044302 | 0.90 | — | — | |
| SCHEMBL29697134 | 0.90 | — | — | |
| SCHEMBL15120165 | 0.90 | — | — | |
| SCHEMBL14988341 | 0.90 | — | — | |
| SCHEMBL14988743 | 0.89 | — | — | |
| SCHEMBL15120187 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250057823-A1 | COMPOSITION FOR IMPROVING CARDIAC FUNCTION | KYOTO UNIVERSITY (JP) | 2025-02-20 | — | — | US | claimed |
| EP-4454648-A1 | COMPOSITION FOR IMPROVING HEART FUNCTION | Kyoto University (JP) | 2024-10-30 | — | — | EP | claimed |
| US-20240216397-A1 | COMPOSITION FOR AMELIORATING SKIN TISSUE ABNORMALITY | KYOTO UNIVERSITY (JP) | 2024-07-04 | — | — | US | claimed |
| US-12011438-B2 | Composition for protecting cardiomyocyte | KYOTO UNIVERSITY (JP) | 2024-06-18 | — | — | US | claimed |
| EP-4331589-A1 | COMPOSITION FOR AMELIORATING ABNORMALITY OF SKIN TISSUE | Kyoto University (JP) | 2024-03-06 | — | — | EP | claimed |
| WO-2023140242-A1 | COMPOSITION FOR PROTECTING TISSUE ISOLATED FROM LIVING BODY | 国立大学法人京都大学 | 2023-07-27 | — | — | WO | claimed |
| WO-2023120704-A1 | COMPOSITION FOR IMPROVING HEART FUNCTION | 国立大学法人京都大学 | 2023-06-29 | — | — | WO | claimed |
| US-20220401461-A1 | Pharmaceutical Composition for Protecting Cartilage | KYOTO UNIVERSITY (JP) | 2022-12-22 | — | — | US | claimed |
| WO-2022230949-A1 | COMPOSITION FOR AMELIORATING ABNORMALITY OF SKIN TISSUE | 国立大学法人京都大学 | 2022-11-03 | — | — | WO | claimed |
| EP-4049724-A1 | PHARMACEUTICAL COMPOSITION FOR PROTECTING CARTILAGE | Kyoto University (JP) | 2022-08-31 | — | — | EP | claimed |
| CN-111757733-A | Composition for protecting cornea | 国立大学法人京都大学 | 2020-10-09 | — | — | CN | claimed |
| WO-2020027137-A1 | MEDICINE COMPOSITION FOR TREATING CEREBRAL INFARCTION | 国立大学法人京都大学 | 2020-02-06 | — | — | WO | claimed |
| WO-2019203176-A1 | PHARMACEUTICAL COMPOSITION FOR PROTECTING MYOCARDIAL CELLS | 国立大学法人京都大学 | 2019-10-24 | — | — | WO | claimed |
| EP-3042658-B1 | MEDICINAL COMPOSITION IMPROVING LEPTIN RESISTANCE | UNIV KYOTO (JP) | 2019-01-16 | — | — | EP | claimed |
| EP-2959903-B1 | MEDICINE FOR TREATING EYE DISEASE | UNIV KYOTO (JP) | 2018-10-03 | — | — | EP | claimed |
| US-9931351-B2 | Method for improving leptin resistance | KYOTO UNIVERSITY (JP) | 2018-04-03 | — | — | US | claimed |
| US-9782420-B2 | Method for treating eye diseases | KYOTO UNIVERSITY (JP) | 2017-10-10 | — | — | US | claimed |
| US-9573887-B2 | Naphthalene derivative | DAITO CHEMIX CORPORATION (JP) | 2017-02-21 | — | — | US | claimed |
| US-20160303144-A1 | Medicinal Composition Improving Leptin Resistance | KYOTO UNIVERSITY (JP) | 2016-10-20 | — | — | US | claimed |
| EP-2599771-B1 | NAPHTHALENE DERIVATIVE | DAITO CHEMIX CORP (JP) | 2016-09-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057823-A1 | COMPOSITION FOR IMPROVING CARDIAC FUNCTION | TNNI3, NPPA, TNNT2 | SUMO2 4148/4885SUMO1 3183/4885SENP7 2221/4885 |
| US-12011438-B2 | Composition for protecting cardiomyocyte | TNNI3, TNNT2, TNNC1 | SUMO2 2295/4885SUMO1 2239/4885SENP7 2498/4885 |
| US-20160303144-A1 | Medicinal Composition Improving Leptin Resistance | LIPC, ADIPOR1, GPR119 | SUMO2 4540/4885SUMO1 4341/4885SENP7 2517/4885 |
| US-20220401461-A1 | Pharmaceutical Composition for Protecting Cartilage | COL2A1, MATR3, COL1A1 | SUMO2 2757/4885SUMO1 1171/4885SENP7 1925/4885 |
| US-20240216397-A1 | COMPOSITION FOR AMELIORATING SKIN TISSUE ABNORMALITY | CUTA, FABP4, MMP13 | SUMO2 3580/4885SUMO1 3459/4885SENP7 2588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.